fastandbulbous
Bluelight Crew
Is 'ring substituted phenmetrazine derivatives as 5HT2a agonists' such a daft idea?
Ring substituted phenmetrazine derivatives would equate to the alpha methylBOM/BOB type of compounds that Shulgin describes as active psychedelics in PIHKAL. The problem comes in that the are by nature secondary and higher amines. Secondary amines are almost exclusively not good 5HT2a agonists, both phenethylamines (N-methyl DOM/DOB) and indole based compounds (N-methyltryptamine, nor-LSD). So the best way of doing it, considering the morpholine ring is analogous to the LSD D-ring, is to N-methylate it, as seen with LSD.
Stick the well known phenethylaminesubstitution patterns onto the phenyl ring and voila! (the benzodifurans/dragonfly compounds would need some creative naming! - Maybe the duck/duckling series. Seriously)
DOM-duck, Donald's lost cousin!
Ring substituted phenmetrazine derivatives would equate to the alpha methylBOM/BOB type of compounds that Shulgin describes as active psychedelics in PIHKAL. The problem comes in that the are by nature secondary and higher amines. Secondary amines are almost exclusively not good 5HT2a agonists, both phenethylamines (N-methyl DOM/DOB) and indole based compounds (N-methyltryptamine, nor-LSD). So the best way of doing it, considering the morpholine ring is analogous to the LSD D-ring, is to N-methylate it, as seen with LSD.
Stick the well known phenethylaminesubstitution patterns onto the phenyl ring and voila! (the benzodifurans/dragonfly compounds would need some creative naming! - Maybe the duck/duckling series. Seriously)
DOM-duck, Donald's lost cousin!

Attachments
Last edited:
